Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Press releases
Media kit
Innovation Awards
Home
BMS to pull Tequin antibiotic from the shelves
May 1, 2006
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
pharmamanufacturing
The
Washington Post
reports that Tequin is being
withdrawn from the market
, due to blood sugar complications that it can cause.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Anticipating AI regulations in pharma manufacturing
FDA decisions to watch in 2024
Raising a modern pharma CDMO
2024 pharma predictions: Regulations, sustainability and culture
Pharma on top for employee pay satisfaction
Production Pulse: What's ahead for manufacturing in 2024?
Load More Content